Concomitant teriparatide plus raloxifene for the treatment of postmenopausal osteoporosis: Results from a randomized placebo-controlled trial

被引：0
|
作者：
Krege, JH
Omizo, M
Schwartz, EN
Eriksen, EF
Cantor, P
Wang, J
Glass, EV
Myers, SL
Deal, C
机构：
[1] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
[2] Oregon Osteoporosis Ctr, Portland, OR USA
[3] Fdn Osteoporosis Res & Educ, Oakland, CA USA
[4] Cleveland Clin Fdn, Ctr Osteoporosis & Metab Bone Dis, Cleveland, OH 44195 USA
来源：
BONE | 2005年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S117 / S117
页数：1
相关论文
共 50 条
  • [21] Zoledronic acid for the treatment of osteoporosis in patients with β-thalassemia: results from a single-center, randomized, placebo-controlled trial
    Voskaridou, Ersi
    Anagnostopoulos, Athanasios
    Konstantopoulos, Kostas
    Stoupa, Eleni
    Spyropoulou, Evgenia
    Kiamouris, Christos
    Terpos, Evangelos
    HAEMATOLOGICA, 2006, 91 (09) : 1193 - 1202
  • [22] SAFETY AND EFFICACY OF ODANACATIB IN THE TREATMENT OF MEN WITH OSTEOPOROSIS: A RANDOMIZED PLACEBO-CONTROLLED TRIAL
    Chapurlat, R. D.
    Orwoll, E.
    Adami, S.
    Binkley, N.
    Langdahl, B.
    Doleckyj, S.
    Giezek, H.
    Scott, B. B.
    Santora, A. C.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 : S53 - S54
  • [23] Raloxifene and body composition and muscle strength in postmenopausal women: a randomized, double-blind, placebo-controlled trial
    Jacobsen, Didy E.
    Samson, Monique M.
    Emmelot-Vonk, Marielle H.
    Verhaar, Harald J. J.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2010, 162 (02) : 371 - 376
  • [24] Raloxifene improves verbal memory in late postmenopausal women: a randomized, double-blind, placebo-controlled trial
    Jacobsen, Didy E.
    Samson, Monique M.
    Emmelot-Vonk, Marielle H.
    Verhaar, Harald J. J.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2010, 17 (02): : 309 - 314
  • [25] Effects of Odanacatib on BMD and Safety in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With Alendronate: A Randomized Placebo-Controlled Trial
    Bonnick, Sydney
    De Villiers, Tobias
    Odio, Alberto
    Palacios, Santiago
    Chapurlat, Roland
    DaSilva, Carolyn
    Scott, Boyd B.
    De Tilleghem, Celine Le Bailly
    Leung, Albert T.
    Gurner, Deborah
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (12): : 4727 - 4735
  • [26] Bone histomorphometric and biochemical marker results of a 2-year placebo-controlled trial of raloxifene in postmenopausal women
    Ott, SM
    Oleksik, A
    Lu, YL
    Harper, K
    Lips, P
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (02) : 341 - 348
  • [27] Ipriflavone in the treatment of postmenopausal osteoporosis - A randomized controlled trial
    Alexandersen, P
    Toussaint, A
    Christiansen, C
    Devogelaer, JP
    Roux, C
    Fechtenbaum, J
    Gennari, C
    Reginster, JY
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (11): : 1482 - 1488
  • [28] Raloxifene as an Adjunctive Treatment for Postmenopausal Women With Schizophrenia: A 24-Week Double-Blind, Randomized, Parallel, Placebo-Controlled Trial
    Usall, Judith
    Huerta-Ramos, Elena
    Labad, Javier
    Cobo, Jesus
    Nunez, Christian
    Creus, Marta
    Garcia Pares, Gemma
    Cuadras, Daniel
    Franco, Jose
    Miquel, Eva
    Cesar Reyes, Julio
    Roca, Mercedes
    SCHIZOPHRENIA BULLETIN, 2016, 42 (02) : 309 - 317
  • [29] Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled phase 3 trial
    de Villiers, T. J.
    Chines, A. A.
    Palacios, S.
    Lips, P.
    Sawicki, A. Z.
    Levine, A. B.
    Codreanu, C.
    Kelepouris, N.
    Brown, J. P.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 (02) : 567 - 576
  • [30] Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled phase 3 trial
    T. J. de Villiers
    A. A. Chines
    S. Palacios
    P. Lips
    A. Z. Sawicki
    A. B. Levine
    C. Codreanu
    N. Kelepouris
    J. P. Brown
    Osteoporosis International, 2011, 22 : 567 - 576
12345